BF Investment Limited (NSE:BFINVEST)
474.90
-9.80 (-2.02%)
Aug 1, 2025, 3:30 PM IST
CTI BioPharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 72.98 | 351.15 | 78.44 | 11.47 | 223.52 | Upgrade |
Short-Term Investments | 3,960 | 2,521 | 1,950 | 1,385 | 807.65 | Upgrade |
Trading Asset Securities | 739.14 | 1,013 | 985.38 | 941.46 | 950.56 | Upgrade |
Cash & Short-Term Investments | 4,772 | 3,885 | 3,014 | 2,338 | 1,982 | Upgrade |
Cash Growth | 22.83% | 28.93% | 28.89% | 17.99% | 129.04% | Upgrade |
Accounts Receivable | 33.67 | 26.05 | 14.53 | 6.89 | 5.74 | Upgrade |
Receivables | 266.66 | 256.68 | 251.04 | 230.99 | 230.45 | Upgrade |
Prepaid Expenses | 2.72 | 0.17 | 0.17 | 0.12 | 0.04 | Upgrade |
Other Current Assets | 270.55 | 269.51 | 269.48 | 266.31 | 266.51 | Upgrade |
Total Current Assets | 5,312 | 4,412 | 3,534 | 2,836 | 2,479 | Upgrade |
Property, Plant & Equipment | 14.92 | 18.78 | 23.31 | 28.99 | 18.84 | Upgrade |
Long-Term Investments | 70,541 | 63,576 | 47,393 | 40,829 | 33,286 | Upgrade |
Long-Term Deferred Tax Assets | - | - | - | 112.21 | 68.15 | Upgrade |
Other Long-Term Assets | 129.66 | 129.79 | 131.12 | 130.05 | 130.17 | Upgrade |
Total Assets | 75,998 | 68,136 | 51,082 | 43,936 | 35,982 | Upgrade |
Accounts Payable | 0.03 | 0.04 | 0.49 | - | 0.02 | Upgrade |
Accrued Expenses | 38.1 | 31.41 | 27.24 | 15.48 | 7.97 | Upgrade |
Current Income Taxes Payable | 12.27 | 25.7 | - | 3.76 | 0.87 | Upgrade |
Other Current Liabilities | 3.05 | 1.17 | - | - | - | Upgrade |
Total Current Liabilities | 53.45 | 58.32 | 27.73 | 19.24 | 8.86 | Upgrade |
Long-Term Deferred Tax Liabilities | 6,945 | 6,065 | 4,154 | 3,539 | 2,997 | Upgrade |
Other Long-Term Liabilities | 0.12 | 0.05 | - | - | - | Upgrade |
Total Liabilities | 6,999 | 6,123 | 4,182 | 3,559 | 3,006 | Upgrade |
Common Stock | 188.34 | 188.34 | 188.34 | 188.34 | 188.34 | Upgrade |
Retained Earnings | 26,297 | 24,082 | 19,753 | 17,164 | 15,190 | Upgrade |
Comprehensive Income & Other | 42,513 | 37,743 | 26,959 | 23,024 | 17,598 | Upgrade |
Shareholders' Equity | 68,999 | 62,013 | 46,900 | 40,377 | 32,976 | Upgrade |
Total Liabilities & Equity | 75,998 | 68,136 | 51,082 | 43,936 | 35,982 | Upgrade |
Net Cash (Debt) | 4,772 | 3,885 | 3,014 | 2,338 | 1,982 | Upgrade |
Net Cash Growth | 22.83% | 28.93% | 28.89% | 17.99% | 129.56% | Upgrade |
Net Cash Per Share | 126.70 | 103.15 | 80.01 | 62.07 | 52.61 | Upgrade |
Filing Date Shares Outstanding | 37.67 | 37.67 | 37.67 | 37.67 | 37.67 | Upgrade |
Total Common Shares Outstanding | 37.67 | 37.67 | 37.67 | 37.67 | 37.67 | Upgrade |
Working Capital | 5,259 | 4,353 | 3,507 | 2,816 | 2,470 | Upgrade |
Book Value Per Share | 1831.78 | 1646.32 | 1245.10 | 1071.94 | 875.45 | Upgrade |
Tangible Book Value | 68,999 | 62,013 | 46,900 | 40,377 | 32,976 | Upgrade |
Tangible Book Value Per Share | 1831.78 | 1646.32 | 1245.10 | 1071.94 | 875.45 | Upgrade |
Machinery | 46.38 | 46.12 | 45.82 | 45.82 | 29.46 | Upgrade |
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.